BR9307712A - Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451) - Google Patents

Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)

Info

Publication number
BR9307712A
BR9307712A BR9307712-2A BR9307712A BR9307712A BR 9307712 A BR9307712 A BR 9307712A BR 9307712 A BR9307712 A BR 9307712A BR 9307712 A BR9307712 A BR 9307712A
Authority
BR
Brazil
Prior art keywords
compound
sym
imi
fungal strain
sesquiterpenes
Prior art date
Application number
BR9307712-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Didier Vincent Renno
Gerard Bernard O'beirne
Brent Raymond Copp
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of BR9307712A publication Critical patent/BR9307712A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR9307712-2A 1992-12-22 1993-12-22 Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451) BR9307712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds
PCT/GB1993/002632 WO1994014814A1 (en) 1992-12-22 1993-12-22 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor

Publications (1)

Publication Number Publication Date
BR9307712A true BR9307712A (pt) 1999-08-31

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307712-2A BR9307712A (pt) 1992-12-22 1993-12-22 Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)

Country Status (23)

Country Link
US (1) US5565486A (2)
EP (1) EP0675888A1 (2)
JP (1) JPH08504804A (2)
KR (1) KR950704324A (2)
AU (1) AU677272B2 (2)
BG (1) BG99736A (2)
BR (1) BR9307712A (2)
CA (1) CA2151251A1 (2)
CZ (1) CZ284121B6 (2)
FI (1) FI953081A7 (2)
GB (2) GB9226724D0 (2)
HU (1) HUT71859A (2)
IL (1) IL108140A (2)
MX (1) MX9400174A (2)
NO (1) NO952483L (2)
NZ (1) NZ258986A (2)
PL (1) PL309628A1 (2)
RU (1) RU95113350A (2)
SG (1) SG67345A1 (2)
SK (1) SK77595A3 (2)
TW (1) TW242141B (2)
WO (1) WO1994014814A1 (2)
ZA (1) ZA939626B (2)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質yp−02908l−aおよびその製造法
WO1988005782A1 (fr) * 1987-02-06 1988-08-11 Snow Brand Milk Products Co., Ltd. NOUVEAUX DERIVES DE 7beta-HYDROXY-4-PREGNENE-3,20-DIONE ET PROCEDES DE PREPARATION
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼa▲下2▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼa↓2阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
CZ284121B6 (cs) 1998-08-12
IL108140A0 (en) 1994-04-12
CZ164695A3 (en) 1995-11-15
GB9503413D0 (en) 1995-04-12
RU95113350A (ru) 1997-06-10
AU5709694A (en) 1994-07-19
GB9226724D0 (en) 1993-02-17
GB2284603B (en) 1996-03-27
WO1994014814A1 (en) 1994-07-07
KR950704324A (ko) 1995-11-17
SG67345A1 (en) 1999-09-21
FI953081A0 (fi) 1995-06-21
CA2151251A1 (en) 1994-07-07
TW242141B (2) 1995-03-01
SK77595A3 (en) 1995-12-06
IL108140A (en) 1997-06-10
FI953081A7 (fi) 1995-06-21
GB2284603A (en) 1995-06-14
NO952483D0 (no) 1995-06-21
US5565486A (en) 1996-10-15
ZA939626B (en) 1994-08-18
AU677272B2 (en) 1997-04-17
HU9501840D0 (en) 1995-08-28
JPH08504804A (ja) 1996-05-28
PL309628A1 (en) 1995-10-30
MX9400174A (es) 1994-07-29
BG99736A (bg) 1996-04-30
EP0675888A1 (en) 1995-10-11
NZ258986A (en) 1996-11-26
NO952483L (no) 1995-08-15
HUT71859A (en) 1996-02-28

Similar Documents

Publication Publication Date Title
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
TW281675B (2)
WO1999030548B1 (en) Method for the preparation of citalopram
TR200401739T4 (tr) Persikuinnin, üretimi ve ilaç olarak kullanımı için bir işlem
EP1437359A3 (en) Novel 3,6-Hemiketals from the Class of 9a-Azalides
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
BR9307712A (pt) Sesquiterpeno, processo para a preparação de um composto, composto, composição farmacêutica e veterinária, e, processo para fermentar cepa fúngica xo6/15/458 (imi 354451)
Chen et al. Biosynthesis of boromycin
AU3382697A (en) Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
Guengerich et al. Biosynthesis of slaframine,(1S, 6S, 8aS)-1-acetoxy-6-aminooctahydroindolizine, a parasympathomimetic alkaloids of fungal origin. II. Origin of pipecolic acid
RU95112519A (ru) (3,4-ди-фторфенокси)метил оксиран и способ его получения
US4751237A (en) Antihypercholesterolemic beta-lactones
NAKAGAWA et al. Inhibition of platelet aggregation by medermycin and it's related isochromanequinone antibiotics
AU569013B2 (en) 2-phenoxymethyl-imidazoline derivatives
BR0109268A (pt) Método de preparação de citalopram, composto e citaplopram
US4487761A (en) Dopamine β-hydroxylase inhibitors
IL100955A0 (en) Polyhydroxycyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SINGARAM et al. Studies on the biosynthesis of the antibiotic streptozotocin (streptozocin) by Streptomyces achromogenes var. streptozoticus feeding experiments with carbon-14 and tritium labelled precursors
DK257083D0 (da) Mikroorganismestammen chromobacterium violaceum, farmaceutisk aktive forbindelser fremstillet med stammen, fremgangsmade til fremstilling af forbindelserne og disses anvendelse som laegemidler
ME00379B (me) Memno peptidi, postupak za njihovo pripremanje i njihova primjena
KR900004939A (ko) 농화학적으로 유용한 활성 성분들의 미생물에 의한 제조 방법
BR0109267A (pt) Método para preparação de citalopram; composto e sua composição farmacêutica
JPS55104885A (en) Composition for promoting multiplication of bifidobacterium
BR9612430A (pt) Compostos macrocìclicos obtidos a partir de unidades de subóxido.
EP0401798A3 (de) Substituierte Aminoalkylbenzolderivate

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal